Charles Schwab’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-116,902
| Closed | -$129K | – | 3495 |
|
|
2025
Q1 | $129K | Sell |
116,902
-9,845
| -8% | -$10.8K | ﹤0.01% | 3311 |
|
|
2024
Q4 | $218K | Buy |
126,747
+18,004
| +17% | +$31K | ﹤0.01% | 3317 |
|
|
2024
Q3 | $270K | Hold |
108,743
| – | – | ﹤0.01% | 3304 |
|
|
2024
Q2 | $263K | Buy |
+108,743
| New | +$263K | ﹤0.01% | 3397 |
|
|
2022
Q2 | – | Sell |
-63,251
| Closed | -$248K | – | 3536 |
|
|
2022
Q1 | $248K | Buy |
63,251
+39,214
| +163% | +$154K | ﹤0.01% | 3269 |
|
|
2021
Q4 | $163K | Hold |
24,037
| – | – | ﹤0.01% | 3385 |
|
|
2021
Q3 | $358K | Buy |
+24,037
| New | +$358K | ﹤0.01% | 3225 |
|